Compare LSCC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSCC | RVTY |
|---|---|---|
| Founded | 1983 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 11.8B |
| IPO Year | 1994 | 1994 |
| Metric | LSCC | RVTY |
|---|---|---|
| Price | $100.56 | $96.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | $102.08 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 05-12-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.02 | ★ 2.07 |
| Revenue | $385,961,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $34.94 | $6.34 |
| Revenue Next Year | $19.93 | $5.10 |
| P/E Ratio | $5,053.50 | ★ $47.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.69 | $81.36 |
| 52 Week High | $108.08 | $120.39 |
| Indicator | LSCC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 63.99 | 41.20 |
| Support Level | $92.88 | $88.56 |
| Resistance Level | $108.08 | $99.65 |
| Average True Range (ATR) | 4.64 | 3.27 |
| MACD | 0.24 | -0.34 |
| Stochastic Oscillator | 66.75 | 25.89 |
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.